Armor Medical, Inc.
Developer of a wrist-worn, non-invasive wearable monitoring platform for early detection of postpartum hemorrhage and related cardiovascular compensation. The company combines optical sensor hardware, signal processing, clinical validation, and cloud-based analytics to deliver real-time alerts and hospital workflow integration. Founded in 2022 and based in Atlanta, GA.
Industries
N/A
Nr. of Employees
small (1-50)
Products
Wrist-worn blood-flow monitoring device
A wrist-worn, non-invasive wearable sensor system that continuously measures peripheral blood flow to provide early detection of postpartum hemorrhage and monitor treatment response in real time.
Wrist-worn blood-flow monitoring device
A wrist-worn, non-invasive wearable sensor system that continuously measures peripheral blood flow to provide early detection of postpartum hemorrhage and monitor treatment response in real time.
Services
Design and conduct of IRB-approved feasibility and clinical studies and pilot integrations with health systems to evaluate device performance and workflow impact.
End-to-end development of wearable device hardware and supporting real-time analytics software optimized for affordability and hospital integration.
Design and conduct of IRB-approved feasibility and clinical studies and pilot integrations with health systems to evaluate device performance and workflow impact.
End-to-end development of wearable device hardware and supporting real-time analytics software optimized for affordability and hospital integration.
Expertise Areas
- Wearable medical device development
- Maternal health monitoring and early hemorrhage detection
- Optical sensing and spectroscopy for physiologic monitoring
- Preclinical and clinical study execution
Key Technologies
- Wearable optical sensors
- Near-infrared and reflectance-mode optics
- Laser-speckle contrast perfusion imaging
- Real-time signal processing and multivariate analytics
News & Updates
Selected as one of ten teams to receive $75,000 and advance to the Technology Assessment phase of the NIH RADx Tech for Maternal Health Challenge.
Named finalist and awarded $25,000 in non-dilutive funding to compete for the MedTech Innovator 2025 Early-Stage Grand Prize.
Awarded the 2025 MedTech Innovator Early Stage Grand Prize (non-dilutive $350,000) to advance the company's wearable maternal monitoring platform.
Catalyst by Wellstar invested to accelerate development and deployment of the wearable maternal monitoring technology and support frontline research and system integration.
Selected as one of 65 startups for the MedTech Innovator 2025 Accelerator program to receive mentorship, strategic guidance, and industry introductions.
Summary of an external article highlighting development of a wrist-worn, non-invasive device for early hemorrhage detection and reporting expected market launch timeline following clinical studies and FDA approval.
Selected as one of ten teams to receive $75,000 and advance to the Technology Assessment phase of the NIH RADx Tech for Maternal Health Challenge.
Named finalist and awarded $25,000 in non-dilutive funding to compete for the MedTech Innovator 2025 Early-Stage Grand Prize.
Awarded the 2025 MedTech Innovator Early Stage Grand Prize (non-dilutive $350,000) to advance the company's wearable maternal monitoring platform.
Catalyst by Wellstar invested to accelerate development and deployment of the wearable maternal monitoring technology and support frontline research and system integration.
Selected as one of 65 startups for the MedTech Innovator 2025 Accelerator program to receive mentorship, strategic guidance, and industry introductions.
Summary of an external article highlighting development of a wrist-worn, non-invasive device for early hemorrhage detection and reporting expected market launch timeline following clinical studies and FDA approval.